Investors / Canada / Genesys Capital
Genesys Capital
Venture capital · Toronto, ON, Canada · North America
Genesys Capital is a life science venture capital firm that invests in and builds companies in biotechnology, pharmaceuticals and medical technology. It has been investing in medical innovation for over 25 years, working with scientific founders and research institutes in North America.
Invests inHealthcare & Biotech
In its own wordsbiotechnologypharmaceuticalsmedical technologylife scienceshealthcareearly stage
Your fit with Genesys Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGenesys Capital lists 8 checked portfolio companies on its own site and is named in 2 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%) and Food & Agriculture (13%). 50% of its companies are based in Canada. It invests most often alongside Lumira Ventures, Arboretum Ventures and Creative Destruction Lab.
Counts come from funding rounds that name Genesys Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 15th | 8 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 95th | 25% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Lumira Ventures | 2 |
| Arboretum Ventures | 1 |
| Creative Destruction Lab | 1 |
| DeepWork Capital | 1 |
| FACIT | 1 |
| Frazier Life Sciences | 1 |
| Hatteras Venture Partners | 1 |
| HealthCap | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers788%
- No longer answers00%
- Points to another company113%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| Food & Agriculture | 13% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Genesys Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Genesys Capital| Date | Company | Stage |
|---|---|---|
| 2 Nov 2026 | Series A | |
| 13 Jan 2026 | Series B Led |
Round details for Genesys Capital
Amounts, full round histories and every co-investor in Genesys Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
8 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adapsyn Bioscience is a chemical bioinformatics company that discovers novel molecules for development as therapeutics, and for use in agriculture, food, and nutrition | Healthcare & Biotech | Portfolio page | ||
Food & Agriculture | Portfolio page | |||
| BIOS Genomics is building the future of genomic interpretation | Healthcare & Biotech | Portfolio page | ||
| EBT Medical is a clinical-stage company developing neuromodulation technologies to treat pelvic health disorders | Healthcare & Biotech | Portfolio page | ||
| Enspire DBS Therapy, Inc. supports stroke recovery patients seeking to restore arm motor function using Deep Brain Stimulation (DBS) in combination with rehabilitation therapy. | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| Flosonics develops and markets a wireless, wearable ultrasound device for real-time hemodynamic assessments to clinicians | Healthcare & Biotech | Portfolio page | ||
| Fusion Pharmaceuticals develops targeted alpha therapeutics for precision medicine to treat cancers | Healthcare & Biotech | Portfolio page | ||
| Specific Biologics develops gene-editing therapies, including a genome editing platform called Dualase, for various diseases | Healthcare & Biotech | Nov 2026Series A | Page + round |
About this data
site last read 8 Nov 2026- Site
- genesyscapital.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 13 Jan 2026
- Companies checked
- 8
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Genesys Capital's profile as data
Pull Genesys Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/genesyscapital.com
# also
GET /v1/firms/genesyscapital.com/portfolio
GET /v1/firms/genesyscapital.com/coinvestors
GET /v1/firms/genesyscapital.com/news